TOP1 and colorectal carcinoma: A first-line chemotherapy prolonging the survival of patient with CRC is the TOP1 inhibitor, CPT that acts by preventing TOP1 ligase activity, which leads to the persistence of single-stranded DNA breaks that evolve into double-stranded DNA breaks, and ultimately cell death (29–31).